Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy

British Journal of Ophthalmology

Volumn 94, Issue 6, 2010, Pages 696-700

  Hamilton, R ^a   McGlone, L ^b   MacKinnon, J R ^a   Russell, H C ^a   Bradnam, M S ^a   Mactier, H ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CANNABIS; DIAMORPHINE; METHADONE;

ABSTINENCE; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONGENITAL MALFORMATION; CONVERGENT STRABISMUS; DISEASE SEVERITY; DIVERGENT STRABISMUS; DRUG ABUSE; ELECTROPHYSIOLOGY; EYE EXAMINATION; FEMALE; HUMAN; INFANT; MEDICAL RECORD REVIEW; MYOPIA; NYSTAGMUS; OPHTHALMOLOGY; ORTHOPTICS; PATIENT REFERRAL; PEDIATRICS; PERINATAL DRUG EXPOSURE; PREGNANCY; PRIORITY JOURNAL; REFRACTION ERROR; RETINA; RETROSPECTIVE STUDY; RISK; STRABISMUS; URINALYSIS; VISION; VISION TEST; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT; WITHDRAWAL SYNDROME;

CHILD; CHILD, PRESCHOOL; EVOKED POTENTIALS, VISUAL; EYE DISEASES; FEMALE; HUMANS; INFANT; MATERNAL-FETAL EXCHANGE; METHADONE; NARCOTICS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS; VISUAL ACUITY;

EID: 77953752573     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.169284     Document Type: Article

References (24)

1. Burns L, Mattick RP, Lim K, et al. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2006;102:264-70. (Pubitemid 46096288)
2. Dryden C, Young D, Hepburn M, et al. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Br J Obstet Gynaecol 2009;116:665-71.
3. Lloyd DJ, Myserscough EJ. Substance misuse research - neonatal abstinence syndrome. A new intervention: a community based, structured health visitor assessment. 2006. Scottish Executive Social Research Substance Misuse Research Programme.
4. Mulvihill AO, Cackett PD, George ND, et al. Nystagmus secondary to drug exposure in utero. Br J Ophthalmol 2007;91:613-5.
5. Farid WO, Dunlop SA, Tait RJ, et al. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol 2008;6:125-50.
6. Hagopian GS, Wolfe HM, Sokol RJ, et al. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med 1996;5:348-54.
7. Giles W, Patterson T, Sanders F, et al. Outpatient methadone programme for pregnant heroin using women. Aust N Z J Obstet Gynaecol 1989;29:225-9. (Pubitemid 19217015)
8. Bauer LO. Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials. Drug Alcohol Depend 1998;50:147-55.
9. McGlone L, Mactier H, Hamilton R, et al. Visual evoked potentials in infants exposed to methadone in utero. Arch Dis Child 2008;93:784-6.
10. Whitham JN, Spurrier N, Sawyer M, et al. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicol Teratol 2009; doi: 10.10.1016/j.ntt.2009.09.001.
11. Mackay AM, Bradnam MS, Hamilton R, et al. Real time rapid acuity assessment using VEPs: development and validation of the 'step VEP' technique. Invest Ophthalmol Vis Sci 2008;49:438-41.
12. Dutton GN. 'Dorsal stream dysfunction' and 'dorsal stream dysfunction plus': a potential classification for perceptual visual impairment in the context of cerebral visual impairment. Dev Med Child Neurol 2009;51:168-72.
13. Sherwood RA, Keating J, Kavvadia V, et al. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 1999;158:488-92. (Pubitemid 29240803)
14. Hidden Harm. The report of the inquiry by the advisory council on the misuse of drugs. London: UK Home Office, 2003.
15. Sarvananthan N, Surendran M, Roberts E, et al. The prevalence of nystagmus: the Leicestershire Nystagmus Survey. Invest Ophthalmol Vis Sci 2009;50:5201-6.
16. Harris C, Berry D. A developmental model of nystagmus. Semin Ophthalmol 2006;21:63-9.
17. Cannon SC, Robinson DA. Loss of the neural integrator of the oculomotor system from brain stem lesions in monkey. J Neurophysiol 1987;57:1383-409.
18. Lin Y, Carpenter DO. Direct excitatory opiate effects mediated by non-synaptic actions on rat medial vestibular neurons. Eur J Pharmacol 1994;262:99-106. (Pubitemid 24271841)
19. Hauser KF, Houdi AA, Turbek CS, et al. Opioids intrisically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation. Eur J Neurosci 2000;12:1281-93.
20. Seatriz JV, Hammer RP. Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res Bull 1993;30:523-7.
21. Mustari MJ, Ono S, Vitorello KC. How disturbed visual processing early in life leads to disorders of gaze-holding and smooth pursuit. Prog Brain Res 2008;171:487-95.
22. Friedman Z, Neumann E, Hyams SW, et al. Ophthalmic screening of 38,000 children, age 1 to 2 1/2 years, in child welfare clinics. J Pediatr Ophthalmol Strabismus 1980;17:261-7.
23. Rothenberg S, Peck EA, Schottenfeld S, et al. Methadone depression of visual signal detection performance. Pharmacol Biochem Behav 1979;11:521-7. (Pubitemid 10143757)
24. Sanchez ES, Bigbee JW, Fobbs W, et al. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia 2008;56:1017-27.